|
Dr. Suto received his doctorate in Biochemistry from Colorado State University under the direction of Professor Richard Finke. During post-doctoral studies with Professor Karolin Luger at Colorado State University he conducted X-ray crystallography studies of nucleosome core particles containing histone variants and DNA binding polyamide ligands. Prior to co-founding Xtal BioStructures, Dr. Suto served as a lead Scientist at Pintex Pharmaceuticals, Inc., a startup company focused on the development of structure-based cancer therapeutics and diagnostics (sold to Vernalis in 2005). His multidisciplinary background in biochemistry, chemistry, and X-ray crystallography was used to build the drug discovery and development programs for Pin1 inhibitors. | 